View Older Stories View More Recent Stories
-
Notable Analyst Rating Changes 12/20: (LHO) (FLIR) (AWAY) Upgraded; (NOK) (SD) (GBX) Downgraded
-
Roth Capital Starts Exact Sciences (EXAS) at Buy
-
Roth Capital Starts EnteroMedics (ETRM) at Buy
-
Roth Capital Starts TrovaGene (TROV) at Buy
-
Elon Musk's SolarCity (SCTY) IPO Opens Higher
-
UPDATE: Elon Musk's SolarCity (SCTY) IPO Prices at $8
-
Roth Capital Downgrades YM BioSciences (YMI) to Neutral
-
SolarCity (SCTY) Lowers Expected IPO Price to $8/Share
-
Notable Mergers and Acquisitions of the Day 12/10: (IN)/(HON) (IR) (HLYS) (AMGN) (AIG)
-
Sequential Brands to Acquire Heelys (HLYS) for $2.25/Share
-
Roth Capital Downgrades Overland Storage (OVRL) to Neutral
-
Derma Sciences (DSCI) Prices 3.06M Offering at $10.34/Share
-
NovaBay Pharma (NBY) Prices 5.9M Common Offering at $1.25/Share
-
Notable Analyst Rating Changes 12/04: (FRAN) (GFI) (SFD) Upgraded; (IACI) (CLF) (RGC) Downgraded
-
Roth Capital Starts Alexza Pharma (ALXA) at Buy
-
BioDelivery Sciences (BDSI) Enters $40M Committed Financing
-
Roth Capital Downgrades Solar Power (SOPW) to Neutral
-
Roth Capital Starts Medgenics (MDGN) at Buy
-
Roth Capital Starts Repros Therapeutics (RPRX) at Buy
-
Prospect Global (PGRX) Closes 15M Common Offering; Net Proceeds Were $24.3M
-
Coastal Contacts (COA) Plans to Sell $40M Common
-
Roth Capital Starts Franklin Covey (FC) at Buy
-
Roth Capital Starts Cell Therapeutics (CTIC) at Buy
-
Roth Capital Starts Capstone Turbine (CPST) at Neutral
-
CytRx (CYTR) Underwriters Exercise Full 1.2M Common Overallotment
-
Aeterna Zentaris (AEZS) Closes 6.6M Unit Offering; Nets $15.2M
-
Roth Capital Resumes Motorcar Parts of America (MPAA) at Buy
-
Aeterna Zentaris (AEZS) Prices 6.6M Offering at $2.50/Unit
-
Roth Capital Starts Acquity Group (AQ) at Buy
-
Aeterna Zentaris (AEZS) Commences Common, Warrant Offering
-
Amarin (AMRN) Rated Buy at Roth Capital, Sees "Blockbuster Potential" for Vascepa
-
Roth Capital Downgrades bebe stores, inc. (BEBE) to Neutral
-
Roth Capital Starts Velti (VELT) at Buy
-
Navarre (NAVR) to Acquire SpeedFC for $50M in Cash, Stock
-
Roth Capital Downgrades 7 Days Group Holdings (SVN) to Neutral
-
Notable Analyst Rating Changes 09/25: (SWY) (GFI) (TIVO) Upgraded; (PAYX) (LEN) (ADP) Downgraded
-
Roth Capital Starts NVIDIA (NVDA) at Buy
-
Wet Seal (WTSLA) Issues Letter to Shareholders and Files Revocation Statement
-
Roth Capital Downgrades Peregrine Pharmaceuticals (PPHM) to Neutral
-
Unusual 11 Mid-Day Movers 09/21: (HALO) (KERX) (SNSS) Higher; (PEIX) (BTH) (KBH) Lower
-
Keryx Biopharma (KERX) Moves Higher on Volume (AEZS)
-
Roth Capital 'Materially' Raises VIVUS (VVUS) Qsymia Sales Expectations; Remains Near-Term Cautious
-
Roth Capital Upgrades Wet Seal, Inc. (WTSLA) to Buy
-
Notable Analyst Rating Changes 09/20: (LTD) (PHM) (HR) Upgraded; (NSC) (X) (HAL) Downgraded
-
Roth Capital Starts Æterna Zentaris (AEZS) at Buy
-
Roth Capital Upgrades Sutor Technology Group (SUTR) to Buy
-
Peregrine Pharmaceuticals (PPHM) Price Target Nearly Doubled
-
Roth Capital Downgrades Digital Domain Media Group (DDMG) to Neutral
-
Notable Analyst Rating Changes 09/06: (AKS) (ATVI) (GOLD) Upgraded; (NOK) (CLF) (OCZ) Downgraded
-
Roth Capital Starts Rigel Pharmaceuticals (RIGL) at Buy

